Alecensa Alectinib 150 Mg Capsules

About Alecensa Alectinib 150 Mg Capsules

Alecensa Alectinib 150 Mg Capsules

Alecensa 150 mg Capsules contain Alectinib, a targeted anti-cancer therapy indicated for the treatment of ALK-positive (Anaplastic Lymphoma Kinase positive) Non-Small Cell Lung Cancer (NSCLC) in adult patients. It works by blocking ALK proteins that promote cancer cell growth, helping to slow disease progression and support treatment outcomes.

This prescription oncology medicine is commonly used under specialist supervision and is designed for oral administration. Alecensa capsules are generally taken with food and should be used strictly as directed by the treating oncologist.

Product Details:

• Product Name: Alecensa Capsules
• Generic Name: Alectinib
• Strength: 150 mg
• Dosage Form: Capsules
• Therapeutic Category: Anti-Cancer / Targeted Therapy
• Indication: ALK-Positive Non-Small Cell Lung Cancer (NSCLC)
• Route of Administration: Oral
• Storage: Store below 30C in a cool and dry place